L-asarinin

CAS No. 133-05-1

L-asarinin( (-)-Episesamin )

Catalog No. M19423 CAS No. 133-05-1

Asarinin reduces peripheral blood concentration of IL-12 and inhibits the expression of CXCR3 and TLR4.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    L-asarinin
  • Note
    Research use only, not for human use.
  • Brief Description
    Asarinin reduces peripheral blood concentration of IL-12 and inhibits the expression of CXCR3 and TLR4.
  • Description
    Asarinin reduces peripheral blood concentration of IL-12 and inhibits the expression of CXCR3 and TLR4 which means Asarinin may have a role on the TLR4 pathway and produce prolongation of allograft heart survival.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (-)-Episesamin
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    133-05-1
  • Formula Weight
    354.36
  • Molecular Formula
    C20H18O6
  • Purity
    >98% (HPLC)
  • Solubility
    Chloroform Dichloromethane Ethyl Acetate Acetone etc.:Soluble;DMSO:Soluble
  • SMILES
    C5O[C@@H](c1ccc2OCOc2c1)[C@H]6CO[C@H](c3ccc4OCOc4c3)[C@@H]56
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gu J. et al. The effect of Asarinin on Toll-like pathway in rats after cardiac allograft implantation. Transplant Proc. 2015 Mar;47(2):545-8.
molnova catalog
related products
  • PACAP (1-38), human,...

    PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP), gastrin releasing peptide (GRP), and VIP release. PACAP 1-38 (10-8 M) inhibited gastrin secretion and stimulated somatostatin secretion and motility dose-dependently.

  • XY101

    XY101 is a selective, metabolically stable and orally available agonist of RORγ inverse(IC50 of 30 nM and a Kd of 380 nM).

  • 10-(Phosphonooxy)dec...

    10-(Phosphonooxy)decyl methacrylate (10-methacryloyloxydecyl dihydrogen phosphate) is an adhesive that can modify the surface of dentin and improve the stability of dentin bonding.